METANOVA: A phase II trial of metastasis-directed radiotherapy for de novo oligometastatic prostate cancer treated with long-term androgen deprivation therapy in the STAMPEDE trial.

Authors: Angela Y. Jia, Joshua Michael Lang, Rohan K. Patel, Himanshu Nagar, Raed Zuhour, Kevin Victor Chaung, Nicholas G. Zaorsky, Prateek Mendiratta, Jonathan E. Shoag, James Robert Janopaul-Naylor, Francesca Khani, Edward M. Schaeffer, Pedro C. Barata, Jason R. Brown, Jorge A. Garcia, Christopher E Barbieri, Yilun Sun, Peter L. Choyke, Daniel Eidelberg Spratt

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps5128

Source: Full article

---

Abstract

TPS5128